Security key
03837C106
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 19,119,856
- Total 13F value
- $66,915,648
- Share change
- +3,292,746
- Put/Call ratio
- 120%
- SEC-reported price per share
- $3.50
- Number of holders
- 59
- Value change
- +$11,936,562
- Number of buys
- 34
- Number of sells
- 19
- Shares outstanding
- 41,921,434
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
59
Top holders
10
APYX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Apyx Medical Corp SEC filings
Apyx Medical Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03837C106
Recent filing periods:
Ownership snapshot
Top reported holders of APYX - Apyx Medical Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Nantahala Capital Managem...
Disclosed value leader
Nantahala Capital Managem...
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G
13F
Lead comparable stake: 10%
13D/G row: Nantahala Capital Management, LLC
Showing 1-6 of 15 holder rows.
Quick read
Nantahala Capital Management, LLC leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Nantahala Capital Management, LLC's linked filing trail.
Comparable ownership
Top 5
Nantahala Capital Management, LLC
10%
Archon Capital Management LLC
7.8%
ROYCE & ASSOCIATES LP
5.9%
VANGUARD GROUP INC
3.6%
Silverberg Bernstein Capital Mana...
2.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC |
13D/G
13F
Company
|
10%
|
$14,394,468
4,112,705 shares
|
+$2,168,145 | 31 Dec 2025 |
| Archon Capital Management LLC |
13F
Company
|
7.8%
|
$7,022,380
3,281,486 shares
|
— | 30 Sep 2025 |
| ROYCE & ASSOCIATES LP |
13F
Company
|
5.9%
|
$5,295,214
2,474,399 shares
|
— | 30 Sep 2025 |
| VANGUARD GROUP INC |
13F
Company
|
3.6%
|
$3,271,947
1,528,947 shares
|
— | 30 Sep 2025 |
| Silverberg Bernstein Capital Management LLC |
13F
Company
|
2.4%
|
$2,111,204
986,503 shares
|
— | 30 Sep 2025 |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
Company
|
1.6%
|
$1,420,000
663,541 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
59
Shares
19,119,856
Rows available
59
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
47
Q4 2025 holders
59
Holder diff
12
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend